Desoximetasone - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for desoximetasone and what is the scope of freedom to operate?

Desoximetasone is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Akorn, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising, Zydus Pharms, Taro Pharm Inds Ltd, Acp Nimble, Altana, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Taro Pharms, and is included in thirty-nine NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Desoximetasone has four patent family members in four countries.

There are seven drug master file entries for desoximetasone. Seventeen suppliers are listed for this compound.

Summary for desoximetasone

International Patents:	4
US Patents:	2
Tradenames:	3
Applicants:	15
NDAs:	39
Drug Master File Entries:	7
Suppliers / Packagers:	17
Bulk Api Vendors:	39
Clinical Trials:	9
Patent Applications:	6,045
Drug Prices:	Drug price trends for desoximetasone
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for desoximetasone
DailyMed Link:	desoximetasone at DailyMed

See drug prices for desoximetasone

Drug Sales Revenue Trends for desoximetasone

See drug sales revenues for desoximetasone

Recent Clinical Trials for desoximetasone

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Wake Forest University Health Sciences	Phase 4
Siriraj Hospital	Phase 3
Siriraj clinical research center	Phase 3

See all desoximetasone clinical trials

Recent Litigation for desoximetasone

Identify potential future generic entrants

District Court Litigation

Case Name	Date
TARO PHARMACEUTICALS U.S.A., INC. v. GLENMARK PHARMACEUTICALS LTD.	2018-08-08
Taro Pharmaceuticals U.S.A., Inc. v. Perrigo UK FINCO Limited Partnership	2015-09-22

See all desoximetasone litigation

Pharmacology for desoximetasone

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for desoximetasone

Anti-Inflammatory Agents
Glucocorticoids

Synonyms for desoximetasone

(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
17-Deoxymethansone
17-Desoximethasone
382-67-2
382D672
4E07GXB7AU
9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione
9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone
A 41-304
A 41304
A-41-304
AB2000738
AC1NSJXQ
AKOS030254657
AS-15787
BDBM50103622
BRN 2228097
C-55186
CAS-382-67-2
CCG-101120
CHEBI:691037
CHEMBL1766
CS-3002
CTK8F9086
D03697
DB00547
Deoxymethasone
Desossimetasone
Desossimetasone [DCIT]
Desoximetason
Desoximetasona
Desoximetasona [INN-Spanish]
Desoximetasone (USP/INN)
Desoximetasone [USAN:USP:INN:BAN]
Desoximetasone pound>>A 41-304 pound>>17-deoxy Dexamethasone pound>>HOE 304
Desoximetasonum
Desoximetasonum [INN-Latin]
Desoxymethasone
Dexamethasone Impurity F
DSSTox_CID_25647
DSSTox_GSID_45647
DSSTox_RID_81025
DTXSID3045647
EINECS 206-845-3
Esperson
Flubason
GTPL7067
HMS2052C15
HMS2236H07
HOE 304
HOE-304
HY-17570
Ibaril
MLS000028654
MLS001076073
MLS001424230
MolPort-003-941-111
NC00370
NCGC00023648-03
NCGC00023648-04
Opera_ID_52
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-
Q-200938
Q790
R 2113
R-2113
SC-46986
SCHEMBL4214
SMR000058856
Stiedex
Topicort
Topicort (TN)
Topicort LP
Topisolon
Tox21_110889
Tox21_110889_1
UNII-4E07GXB7AU
VWVSBHGCDBMOOT-IIEHVVJPSA-N
ZINC4212854

US Patents and Regulatory Information for desoximetasone

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Akorn	DESOXIMETASONE	desoximetasone	GEL;TOPICAL	090727-001	Mar 10, 2011	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Taro Pharms	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	AT	RX	Yes	Yes	Start Trial	Start Trial	Y			Start Trial
Taro Pharm Inds Ltd	TOPICORT	desoximetasone	CREAM;TOPICAL	073193-001	Nov 30, 1990	AB	RX	No	Yes	Start Trial	Start Trial				Start Trial
Perrigo New York	DESOXIMETASONE	desoximetasone	CREAM;TOPICAL	076510-001	Jul 1, 2003	AB	RX	No	No	Start Trial	Start Trial				Start Trial
Zydus Pharms	DESOXIMETASONE	desoximetasone	CREAM;TOPICAL	205620-001	Sep 28, 2018		DISCN	No	No	Start Trial	Start Trial				Start Trial
Lupin Atlantis	DESOXIMETASONE	desoximetasone	SPRAY;TOPICAL	208124-001	Mar 16, 2018	AT	RX	No	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for desoximetasone

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro Pharms	TOPICORT	desoximetasone	SPRAY;TOPICAL	204141-001	Apr 11, 2013	Start Trial	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for desoximetasone

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2006130510	Start Trial
Canada	2609579	Start Trial
Israel	187666	Start Trial
European Patent Office	1888026	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.